Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS
· Delayed Price · Currency is USD
0.0541
-0.0159 (-22.71%)
At close: Apr 29, 2026
Hepion Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1.83 | 0.41 | 14.79 | 51.19 | 91.35 | Upgrade
|
| Cash & Short-Term Investments | 1.83 | 0.41 | 14.79 | 51.19 | 91.35 | Upgrade
|
| Cash Growth | 349.81% | -97.25% | -71.11% | -43.96% | 124.30% | Upgrade
|
| Prepaid Expenses | 1.24 | 1.21 | 2.7 | 5.31 | 6.1 | Upgrade
|
| Total Current Assets | 3.07 | 1.61 | 17.49 | 56.5 | 97.45 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.24 | 0.13 | 0.46 | Upgrade
|
| Goodwill | - | - | - | - | 1.87 | Upgrade
|
| Other Intangible Assets | - | - | - | 3.19 | 3.19 | Upgrade
|
| Other Long-Term Assets | - | - | 0.36 | 0.43 | 0.58 | Upgrade
|
| Total Assets | 3.07 | 1.61 | 18.09 | 60.24 | 103.55 | Upgrade
|
| Accounts Payable | 0.17 | 0.22 | 2.35 | 2.67 | 2.45 | Upgrade
|
| Accrued Expenses | 0.08 | 0.02 | 1.74 | 4.8 | 2.51 | Upgrade
|
| Short-Term Debt | 0.05 | 2.9 | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.12 | 0.05 | 0.27 | Upgrade
|
| Other Current Liabilities | - | - | 1.09 | 0.37 | 2.99 | Upgrade
|
| Total Current Liabilities | 0.3 | 3.14 | 5.29 | 7.89 | 8.21 | Upgrade
|
| Long-Term Leases | - | - | 0.09 | - | 0.05 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.41 | 0.41 | Upgrade
|
| Other Long-Term Liabilities | 0.1 | 0.33 | 5.43 | 2.09 | 1.89 | Upgrade
|
| Total Liabilities | 0.4 | 3.48 | 10.81 | 10.39 | 10.56 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 247.06 | 234.25 | 230.29 | 223.95 | 224.79 | Upgrade
|
| Retained Earnings | -246.1 | -237.82 | -224.63 | -175.7 | -133.5 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.01 | -0.08 | -0.09 | - | Upgrade
|
| Total Common Equity | 0.97 | -3.56 | 5.59 | 48.16 | 91.29 | Upgrade
|
| Shareholders' Equity | 2.67 | -1.86 | 7.28 | 49.86 | 93 | Upgrade
|
| Total Liabilities & Equity | 3.07 | 1.61 | 18.09 | 60.24 | 103.55 | Upgrade
|
| Total Debt | 0.05 | 2.9 | 0.21 | 0.05 | 0.32 | Upgrade
|
| Net Cash (Debt) | 1.77 | -2.49 | 14.58 | 51.14 | 91.03 | Upgrade
|
| Net Cash Growth | - | - | -71.49% | -43.83% | 127.72% | Upgrade
|
| Net Cash Per Share | 0.19 | -20.29 | 183.55 | 670.81 | 1295.05 | Upgrade
|
| Filing Date Shares Outstanding | 11.62 | 10.98 | 0.11 | 0.08 | 0.08 | Upgrade
|
| Total Common Shares Outstanding | 11.62 | 0.14 | 0.1 | 0.08 | 0.08 | Upgrade
|
| Working Capital | 2.77 | -1.53 | 12.2 | 48.61 | 89.25 | Upgrade
|
| Book Value Per Share | 0.08 | -25.57 | 57.96 | 631.77 | 1197.69 | Upgrade
|
| Tangible Book Value | 0.97 | -3.56 | 5.59 | 44.97 | 86.23 | Upgrade
|
| Tangible Book Value Per Share | 0.08 | -25.57 | 57.96 | 589.92 | 1131.29 | Upgrade
|
| Machinery | - | - | 0.41 | 0.39 | 0.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.